Research never stops

Euprotec Ltd belongs to Evotec Group

In May 2014, Evotec acquired all of the shares in Euprotec Ltd (Manchester), a UK based specialty Contract Research Organisation (CRO) delivering a comprehensive range of R&D and infectious disease biology services; and offering highly collaborative and flexible research model supporting antimicrobial drug discovery activities through to late-stage pre-clinical investigation and clinical proof-of-concept studies.

The integration of Euprotec's unique capabilities augmented and complemented Evotec's high-end drug discovery platform with anti-infective screening, early PKPD (Pharmacokinetic/Pharmacodynamic) profiling, an extensive range of disease and efficacy models for characterisation of anti-bacterials, anti-fungals and anti-virals, EvostrAIn™, a unique collection of clinical isolates, and added core disease biology know-how in infection. These skills further enhanced Evotec's ability to deliver high-quality innovative solutions to its partners on a global scale.

For more information please go to Anti-infectives or contact us at

loading weather report
Loading weather report...


Feb 27, 2018 - CED Life Science Conference

Mar 13, 2018 - 24th Prior Kapitalmarktkonferenz

Company Presentation February

Building integrated and high-value drug discovery alliances
2018-02_Evotec_Company presentation_February